Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy Adolescents

NCT02075203 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

989

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

BIOLOGICAL: AERAS-404
DRUG: Placebo
BIOLOGICAL: Bacillus Calmette-Guérin (BCG)

Sponsor

Aeras

Collaborators

[object Object]